Sutro Biopharma, Inc. (STRO)
NASDAQ·Healthcare·Biotechnology
$29.00
+9.52%
Mkt Cap $212.66M
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$50.75
Range $43.00 – $60.00
Implied Upside
+75.0%
Consensus $50.75 vs current $29.00
NASDAQ·Healthcare·Biotechnology
$29.00
+9.52%
Mkt Cap $212.66M
No recent rating data.
Price Target (16 analysts)
$50.75
Range $43.00 – $60.00
+75.0%
Consensus $50.75 vs current $29.00